🇺🇸 FDA
Patent

US 10131659

Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

granted A61KA61K31/381A61K31/4745

Quick answer

US patent 10131659 (Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/381, A61K31/4745, A61P, A61P35/00